Sofia Doubrovinskaia

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.

Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.

Journal: Blood

Published: September 30, 2025

Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Journal: Blood

Published: September 30, 2025

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma.

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma.

Journal: Journal of hematology & oncology

Published: August 27, 2025

Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.

Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.

Journal: Blood

Published: February 24, 2025

Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas.

Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas.

Journal: Neuro-oncology

Published: November 22, 2024

Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis.

Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis.

Journal: American journal of hematology

Published: September 19, 2024

Clinical Presentation, Management, and Outcome in Neurolymphomatosis: A Systematic Review.

Clinical Presentation, Management, and Outcome in Neurolymphomatosis: A Systematic Review.

Journal: Neurology

Published: August 05, 2024

Factors influencing timely diagnosis in neurolymphomatosis.

Factors influencing timely diagnosis in neurolymphomatosis.

Journal: Journal of neuro-oncology

Published: May 31, 2024

Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.

Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.

Journal: Acta neuropathologica

Published: May 28, 2023

Case report: A 33 years-old alcoholic male with diarrhea and progressive muscle weakness mimicking Guillain-Barré syndrome.

Case report: A 33 years-old alcoholic male with diarrhea and progressive muscle weakness mimicking Guillain-Barré syndrome.

Journal: Frontiers in neurology

Published: April 26, 2023

Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up study.

Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up study.

Journal: European journal of neurology

Published: May 30, 2022

Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series.

Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series.

Journal: European journal of neurology

Published: July 19, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026